ELV
Elevance Health, Inc.
Stock
$386.43+4.76 (+1.25%)Close Oct 2, 2026
- Free cash flow, 2025
- $3.2B
- YoY, 2025
- −30.3%
- 5-year CAGR
- −20.0%
- 10-year CAGR
- −1.2%
Free cash flow
Free cash flow by fiscal year
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $3.2B | −30.3% |
| 2024 | $4.6B | −32.7% |
| 2023 | $6.8B | −6.7% |
| 2022 | $7.2B | −0.4% |
| 2021 | $7.3B | −24.7% |
| 2020 | $9.7B | +94.0% |
| 2019 | $5.0B | +90.3% |
| 2018 | $2.6B | −22.8% |
| 2017 | $3.4B | +26.4% |
| 2016 | $2.7B | −24.8% |
| 2015 | $3.6B | +34.6% |
| 2014 | $2.7B | +10.3% |
| 2013 | $2.4B | +9.4% |
| 2012 | $2.2B | −23.0% |
| 2011 | $2.9B | +195.8% |
| 2010 | $965M | −63.7% |
| 2009 | $2.7B | +21.5% |
| 2008 | $2.2B | −45.6% |
| 2007 | $4.0B | — |